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Abstract
Background—We examined mammography use before and after Medicare eliminated cost 
sharing for screening mammography in January 2011.
Methods—Using National Health Interview Survey data, we examined changes in 
mammography use between 2010 and 2013 among Medicare beneficiaries aged 65–74 years. 
Logistic regression and predictive margins were used to examine changes in use after adjusting for 
covariates.
Results—In 2013, 74.7% of women reported a mammogram within 2 years, a 3.5 percentage 
point increase (95% confidence interval, −0.3, 7.2) compared with 2010. Increases occurred 
among women aged 65–69 years, unmarried women, and women with usual sources of care and 
2–5 physician visits in the prior year. After adjustment, mammography use increased in 2013 
versus 2010 (74.8% vs. 71.3%, P = 0.039). Interactions between year and income, insurance, race, 
or ethnicity were not significant.
Conclusions—There was a modest increase in mammography use from 2010 to 2013 among 
Medicare beneficiaries aged 65–74 years, possibly consistent with an effect of eliminating 
Medicare cost sharing during this time. Findings suggest that eliminating cost sharing might 
increase use of recommended screening services.
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Medicare provides health care coverage to most Americans aged 65 years and older. Breast 
cancer has a substantial impact on the female Medicare population. Risk increases with age,1 
with incidence rates considerably higher among women aged 65 years and older compared 
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with younger women, and most breast cancer deaths occurring in this age group.2 Screening 
mammography increases early detection of breast cancer, which leads to earlier treatment, 
and reductions in mortality. Its use is recommended by the US Preventive Services Task 
Force (USPSTF) every 2 years for women aged 50–74 years.1 Thus many Medicare 
beneficiaries are eligible for screening.
For beneficiaries aged 65 years and older, Medicare Part B covers screening mammograms.3 
Initially, coverage was subject to deductible and coinsurance.4 In 1997 legislation waived the 
deductible, but a 20% coinsurance remained,5,6 translating to approximately $15–$40 per 
mammography.7 Despite coverage, many women with Medicare coverage have not received 
a recent mammogram.8 Furthermore, cancer screening uptake is lower for some groups, with 
differences in use by race and ethnicity8 and type of Medicare coverage8,9 described. For 
example, among traditional Medicare beneficiaries, black, Hispanic, and Asian or Pacific 
Islander women were less likely to have had a recent mammogram than white women, 
although this was not found among those in Medicare health maintenance organizations.8
Multiple barriers to screening have been described, including access to and cost of screening 
services.10,11 Lower income and uninsured women are less likely than women with higher 
income or insurance coverage to use screening services.12,13 Cost may be a barrier to 
screening in the Medicare population as well, with Medicare beneficiaries without 
supplemental insurance to defray costs less likely to receive screening than those with 
supplemental coverage.4,9,14 Although some report no detrimental effect of cost sharing on 
recommended cancer screening use, including mammography,15,16 others indicate it may 
have a negative effect. Cost sharing has been associated with lower mammography use,17–19 
and some suggest that negative effects of cost sharing may be greater for mammography 
than other preventive services19 and that deductibles or coinsurance might have a greater 
negative effect on mammography than other forms of cost sharing.19 Differences in cost 
sharing by type of Medicare coverage have also been suggested to possibly contribute to 
racial and ethnic differences in mammography use among beneficiaries.8
Beginning January 1, 2011, for services covered by Medicare, the Affordable Care Act 
required coverage without cost sharing for preventive services rated “A” (strongly 
recommended) or “B” (recommended) by the USPSTF, including screening mammography.
20,21
 The purpose of the current analysis was to examine whether mammography use 
increased after elimination of Medicare cost sharing for screening mammography and 
whether changes varied for different groups of women.
METHODS
We used data from the 2005, 2008, 2010, and 2013 National Health Interview Survey 
(NHIS), an annual survey administered through in-person interviews of a nationally 
representative sample of the civilian, noninstitutionalized US population. We used these 
survey years because these are the most recent years that provide information about USPSTF 
guideline-concordant mammography use. Response rates were 60.8%–69.0%. More 
information on the NHIS is available elsewhere (http://www.cdc.gov/nchs/nhis).
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We included female Medicare beneficiaries without breast cancer history who were 65–74 
years of age. Women in this age group without Medicare coverage were not included. 
Women with previous breast cancers were excluded because they would be subject to 
recommendations for annual surveillance mammography22 rather than general population 
screening which is the focus of this analysis.
We first examined the proportion of women in each year up-to-date with USPSTF guidelines 
for mammography screening. Our dependent variable was reporting having received a 
mammogram in the prior 2 years (recent mammogram), consistent with USPSTF 
recommendations.1 For 2010 (n = 1429) and 2013 (n = 2152), we compared mammography 
use by each factor within year using Pearson Wald F tests. In order to examine whether 
mammography use changed between 2010 and 2013, we calculated the difference between 
years in screening use with 95% confidence intervals (CI). To examine whether any changes 
were new in 2013 versus continuations of ongoing trends, we plotted the proportion of 
women up-to-date with mammography screening in 2005, 2008, 2010, and 2013.
We used multivariable logistic regression to determine whether mammography use changed 
between 2010 and 2013, after adjusting for potential differences in other factors between 
years. We included as covariates several socio-demographic factors shown in previous 
literature to be associated with cancer screening use, including age (65–69 y, 70–74 y), race 
(white, black, Asian, American Indian/Alaska Native), ethnicity (Hispanic, non-Hispanic), 
birthplace (born in US, foreign-born), marital status (married/living with partner, 
unmarried/not living with partner), and income (as a percentage of poverty thresholds).8,12,23 
We also included measures of access to care, including type of insurance (Medicare with 
private supplement, Medicare and Medicaid, Medicare with other supplement, Medicare 
Advantage, traditional Medicare only), having a usual source of care (yes, no), and number 
of provider visits in the prior year (0, 1, 2–5, ≥6), and health status (excellent/very good/
good, fair/poor) as these have also been shown to be related to screening use.7,12,24 
Nonbreast cancer history (yes, no) was also included as a covariate given that prior 
experience with cancer may influence motivation to screen. Missing income data were 
imputed by National Center for Health Statistics (NCHS) using multiple imputation.25 The 
model included survey year and all other covariates as predictors. Results are presented as 
predictive margins, which represent the average predicted response if the entire sample had 
been in a given group.26 Thus, predictive margins, or adjusted percentages, account for 
covariates in the model. By including survey year in the model, we were able to calculate 
predictive margins separately for 2010 and 2013. This enabled us to examine whether 
mammography use changed over time after accounting for differences in other covariates 
between years. We hypothesized that elimination of cost sharing might have a greater effect 
on mammography use among those with lower income or no supplemental insurance. To 
examine these questions and whether cost sharing elimination would influence differences in 
use by race or ethnicity, we decided a priori to include in the model interactions between 
year and income, insurance, race, and ethnicity. Nonsignificant interaction terms were 
removed from the final model.
Because Medicare Advantage plans may not have been required to eliminate cost sharing for 
recommended preventive services until 2012,27 we also examined mammography use 
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excluding Medicare Advantage enrollees. We weighted all statistics and used SUDAAN 
version 11.0.1 (Research Triangle Institute, Research Triangle Park, NC) and SAS version 
9.3 (SAS Institute Inc., Cary, NC) to account for the complex survey design.
RESULTS
Most women were white, non-Hispanic, US-born, had usual sources of care, visited a 
physician at least twice the prior year, and reported at least good health (Table 1). 
Approximately 50%–55% of women had supplemental private insurance, 8%–9% had dual 
Medicare/Medicaid coverage, 13%–19% had Medicare Advantage, and 18%–21% had 
traditional Medicare only. Women were more likely to have higher income and Medicare 
Advantage in 2013 than in 2010.
Compared with earlier years, in 2013 mammography use seems to have increased (Fig. 1). 
Overall, 74.7% reported having a recent mammogram in 2013 (Table 2). This reflects a 3.5 
percentage point increase (95% CI, −0.3 to 7.2) compared with 2010. Women aged 65–69 
years experienced a 6.1 percentage point increase, leading to a difference in mammography 
use by age in 2013 (76.9% vs. 71.8%, P = 0.027) not present in 2010. Non-Hispanic women 
experienced a 4.0 percentage point increase (95% CI, 0.0–8.0). In both years, unmarried 
women had lower mammography use than married women, although use for unmarried 
women increased 5.3 percentage points (95% CI, 0.5–10.1) in 2013. In both years, use was 
also directly related to income, and dual Medicare/Medicaid coverage or traditional 
Medicare only was associated with lower use than supplemental private insurance or 
Medicare Advantage. No clear changes over time by income or insurance were present. 
Mammography use among women lacking a usual source of care was low, however, 
numbers were small and estimates imprecise. There was a modest increase in use for women 
with usual sources of care. Fewer than 2 physician visits the prior year and fair/poor health 
status were associated with lower mammography use in both years, with particularly low 
uptake for those with no visits (30%–35%). Women with 2–5 visits experienced a 7.0 
percentage point increase over time; those with at least good health experienced a 3.5 
percentage point increase (95% CI, −0.6 to 7.5). In multivariable analysis (Table 3), 
mammography use was significantly higher in 2013 than 2010 (predictive margins 74.8% vs. 
71.3%, P = 0.039). No interactions were significant.
Excluding Medicare Advantage enrollees (not shown), before adjustment mammography use 
increased 4.2 percentage points (95% CI, 0.3–8.0). This increase persisted in multivariable 
analysis (predictive margins 75.0% vs. 70.9%, P = 0.025).
DISCUSSION
Among female Medicare beneficiaries 65–74 years old, there was a 3.5 percentage point 
increase in mammography use in 2013 compared with 2010 that was not attributable to 
differences between years in multiple population socio-demographic, health, and health care 
access factors. Given the lack of a previous increase in mammography use in this age group 
or among all age-eligible women since the early-mid 2000s,12,13,28 a small increase is 
notable. Our trends analysis indicates that although the increase in 2013 is fairly small, it 
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seems to be new compared with earlier years which may support a possible effect from 
eliminating cost sharing in 2011. However, findings are from a single data year early after 
the Medicare change. Continued monitoring is needed to confirm findings and if so, to 
determine whether use will continue to increase.
The finding of increased mammography use is consistent with previous literature on the 
effect of cost sharing and its elimination on cancer screening use. Although not supported by 
some,15,16 multiple studies have concluded that cost sharing has a negative effect on use of 
mammography or other cancer screening tests or preventive services,10,17–19,29 and the 
effect may be greater for mammography than for other preventive services.19 Elimination of 
cost sharing has also been associated with increases in use.24,30 Several earlier studies 
included adults aged younger than 65 years. However, elderly adults may be more 
susceptible to effects of cost sharing, given that they may be more likely to have chronic 
conditions which increase out-of-pocket costs for other services.17 Specific to the Medicare 
population, among Medicare-managed care plan enrollees, mammography use declined 
between 2002 and 2004 for women enrolled in plans that instituted cost sharing during this 
time period compared with a modest increase in plans that did not.17 Furthermore, 
mammography use increased among Medicare fee-for-service beneficiaries after waiver of 
the Medicare deductible for mammography in 1997.24 Our finding of increased 
mammography use among Medicare beneficiaries, particularly younger beneficiaries, in 
2013 is consistent with these earlier findings about effects of reducing out-of-pocket costs on 
screening, and expands the evidence to include the recent elimination of Medicare cost 
sharing for mammography screening. Our findings may suggest that cost may have remained 
a barrier to screening for some women even after previous reductions in cost sharing.
Although women in our sample were insured and in 2013 were not required to pay out-of-
pocket for screening mammography, one quarter of women of screening age did not report 
having a recent mammogram in 2013. Furthermore, except for unmarried women increases 
were not observed among groups experiencing screening disparities in 2010 (women with 
lower income, dual Medicare/Medicaid coverage, or traditional Medicare only, no usual 
source of care, <2 visits, or fair/poor health status). For measures such as eliminating cost 
sharing to have the intended effect of increasing access to and utilization of recommended 
services, beneficiaries must be aware of and understand cost sharing exemptions applicable 
to them. A study of consumer-directed health plan beneficiaries found that most did not 
understand that preventive tests were exempted from cost sharing, and for some this created 
barriers to seeking recommended care.31 Whether this is also an issue for Medicare 
beneficiaries is uncertain. Additional barriers beyond cost may also exist for some women. 
Multiple barriers to screening have been described, including patient, provider, and practice 
or organizational factors. For women, factors such as knowledge, attitudes, awareness, and 
availability of screening may influence use.32,33 Not receiving a provider recommendation 
for screening is commonly reported among those not screened,34 and competing demands 
for provider time may also be an issue.35 Practice or organizational systems to prompt, 
encourage, and support providers in delivering or referring patients for screening are 
effective in increasing cancer screening use.32,36 In the current analysis, increases in 
mammography use did occur among those who had usual sources of care and visited a 
physician 2–5 times within the prior year. These findings suggest that increases occurred 
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among women who access the health care system and have opportunities to receive 
recommendations and screening referrals.
Given our study design, we cannot be certain that eliminating cost sharing caused the 
increase in mammography use. Other temporally related factors may have contributed. 
Beyond eliminating cost sharing for screening mammography, the Affordable Care Act 
effected other changes in Medicare during this time, including eliminating cost sharing for 
the “Welcome to Medicare” physical, and establishing an annual wellness visit free from 
cost sharing that might include developing personal screening schedules for beneficiaries.
20,21
 Screening use might have been influenced indirectly through enhanced access to and 
discussion with providers as a result of these changes rather than directly through reduced 
mammography cost. Furthermore, USPSTF updated mammography screening guidelines in 
November 2009. However, the update is unlikely to have played a substantial role in our 
findings. The increased mammography use was driven by an increase among women in their 
60s; no increase was found for women aged 70–74 years. However, guidelines were 
essentially unchanged for women in their 60s, making it unlikely that revised guidelines 
contributed to findings.1,37 Evidence from survey data in earlier years suggests that 
mammography use did not change after the 2009 USPSTF update.23,38
Findings need to be interpreted in light of several limitations. First, our study did not include 
a comparison group to account for trends unrelated to changes in cost sharing policies. We 
did not compare mammography use with changes in other cancer screening tests 
recommended in this age group (eg, colorectal cancer screening) because this screening was 
also subject to changes in Medicare cost sharing during this time.7,24 We did not separately 
examine women with Medicare Part A only who may be less likely to receive 
mammography,39 because there were <30 such women for each year. Second, elimination of 
cost sharing for some Medicare Advantage plans may not have occurred until 201227 
potentially biasing findings toward the null. Exclusion of these beneficiaries did not 
substantially change findings. Third, data were self-reported. However, we do not expect any 
differences in mammography reporting to vary by year. Fourth, 2010 and 2013 NHIS 
response rates were approximately 61% although weights included adjustments for 
nonresponse. Furthermore, some subgroups were small, leading to wide CIs, estimate 
imprecision, and reduced power to detect change over time. Percentages in the figure were 
unadjusted. However, for 2010 and 2013, unadjusted percentages were within 0.2 percentage 
points of adjusted percentages. Finally, diagnostic mammograms might have been included 
possibly leading to overestimates of screening use
In summary, there was a modest increase in mammography use from 2010 to 2013 among 
Medicare beneficiaries aged 65–74 years, which could be consistent with an effect of 
eliminating cost sharing within Medicare during this time. Findings suggest that eliminating 
cost sharing might increase use of recommended screening services. For mammography, this 
increase translates into an additional 390,758 women aged 65–74 years reporting a recent 
mammogram in 2013 compared with 2010. Continued monitoring of mammography use and 
confirmation of findings is needed. Our findings for 2013 reflect the initial 2-year screening 
interval after the change in cost sharing and are therefore relatively short-term results. Lack 
of increased mammography use for some groups may reflect nonfinancial barriers to care. 
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Future efforts to identify and address such barriers may further increase recommended 
screening use in this population.
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FIGURE 1. 
Mammography trends among Medicare beneficiaries aged 65–74 years. NHIS indicates 
National Health Interview Survey.
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TABLE 1
Sociodemographic, Health and Health Care Access Characteristics of Female Medicare Beneficiaries Aged 
65–74 Years, by Survey Year (Weighted Percentages)
2010 2013
n % (95% CI) n % (95% CI)
Total 1429 100% 2152 100%
Age (y)
 65–69 757 54.1 (51.0–57.2) 1195 56.6 (54.2–59.0)
 70–74 672 45.9 (42.8–49.0) 957 43.4 (41.0–45.8)
Race
 White 1101 85.2 (83.1–87.1) 1692 83.9 (82.1–85.6)
 Black 253 10.7 (9.2–12.4) 332 10.8 (9.5–12.3)
 Asian 63 3.4 (2.5–4.7) 103 4.6 (3.6–5.8)
 AIAN 10 * 24 *
Ethnicity
 Hispanic 180 8.2 (6.8–9.7) 236 8.0 (6.8–9.4)
 Non-Hispanic 1249 91.8 (90.3–93.2) 1916 92.0 (90.6–93.2)
Foreign-born status
 Born in US 1202 87.8 (85.7–89.6) 1819 86.3 (84.4–88.1)
 Foreign-born 227 12.3 (10.6–14.3) 332 13.9 (12.1–15.8)
Marital status†
 Married 559 53.4 (50.4–56.5) 912 57.8 (55.3–60.2)
 Unmarried 866 46.6 (43.5–49.6) 1238 42.2 (39.8–44.7)
Income (% poverty threshold)
 < 139 392 20.9 (18.2–23.9) 517 18.2 (16.2–20.4)
 139–250 354 23.5 (20.9–26.3) 513 23.9 (21.5–26.4)
 251–400 334 25.8 (22.7–29.2) 469 21.9 (19.5–24.5)
 > 400 348 29.7 (26.2–33.4) 653 36.0 (33.4–38.8)
Health insurance
 Medicare+private 685 54.2 (51.1–57.3) 1012 49.5 (46.9–52.1)
 Medicare+Medicaid‡ 180 8.6 (7.1–10.4) 249 8.8 (7.5–10.3)
 Medicare+other§ 43 * 81 4.4 (3.2–5.9)
 Medicare Advantage only 204 13.4 (11.5–15.7) 363 19.0 (16.9–21.3)
 Traditional Medicare|| only 307 20.4 (18.1–22.8) 429 18.4 (16.3–20.7)
Usual source of care
 Yes 1358 96.9 (95.8–97.7) 2058 95.9 (94.7–96.9)
 No 53 3.1 (2.3–4.2) 85 4.1 (3.1–5.3)
# Physician visits prior year
 None 107 6.4 (5.1–8.0) 146 6.8 (5.6–8.3)
 1 137 10.4 (8.5–12.7) 254 10.9 (9.4–12.7)
 2–5 652 48.2 (45.1–51.4) 970 46.4 (43.8–49.1)
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2010 2013
n % (95% CI) n % (95% CI)
 ≥6 504 34.9 (31.9–38.2) 746 35.8 (33.2–38.4)
Health status
 Excellent/very good/good 1093 80.4 (78.1–82.5) 1722 81.0 (79.0–82.9)
 Fair/Poor 335 19.6 (17.5–21.9) 429 19.0 (17.1–21.0)
Cancer history¶
 Yes 109 8.8 (7.2–10.7) 198 10.0 (8.4–11.9)
 No 1320 91.6 (89.8–93.1) 1954 90.4 (88.6–92.0)
*
Estimate suppressed because denominator <50 and/or relative SE > 30%.
†
Includes married or living with partner versus unmarried/not living with partner.
‡
Includes those with other state-sponsored insurance.
§
Includes military plans, other government plans, or Indian Health Service.
||
Includes Medicare Part A and/or Part B.
¶
Excludes breast cancer or nonmelanoma skin cancer.
AIAN indicates American Indian/Alaska Native; CI, confidence interval.
Data Source: CDC/NCHS, National Health Interview Survey, 2010 and 2013.
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TABLE 3
Adjusted Proportions of Female Medicare Beneficiaries Aged 65–74 Years Reporting Having Received a 
Mammogram Within the Prior 2 Years, 2010 and 2013
%* 95% CI P
Year
 2010 71.3 68.3–74.2 0.0388
 2013 74.8 72.6–76.9
*Adjusted for age, race, ethnicity, birthplace, marital status, income, insurance, usual source of care, number of visits in prior year, health status, 
and cancer history.
Data Source: CDC/NCHS, National Health Interview Survey, 2010 and 2013.
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